Johnson & Johnson Consumer Inc.

Janssen Pharmaceuticals, Inc.

Janssen Pharmaceutica Nv

Janssen Biotech, Inc.

Tropicana Products, Inc.

Orbit Biomedical Limited

Michael G Cannamela

Max Hunter Knecht

Peter A Krulevitch

Evan Rhodes

Timothy S O'Toole

Aimee Lyn Sealfon

Anthony B Gallo

Ernesto Quinteros

Raffaele Mazzei

Melissa Dandy

Nick Foley

James McLusky

Jimmy Mower

Peter E Arnell

Marc T Wiescinski

Brent S Nelson

Ian Scrimgeour

Jung-ah Suh

Jonathan Kim

Stephane Robic

Nicole Green

Matt Meisner

Paul Gahlman

Tim Mazurkiewicz

Sabrina Adami

Rochelle Kleinberg

Kui Liu

Simone Nenning

Hong Yan

James Glencross

Jingli Wang

Steven M Vesole

Scott Martin

Thomas Zauser

Kostadinka LiLova

Gordon Kosovan

Elaine Hughes

Maria Ficchi

William H Cagney

Chaley J Larson

Jimmy Vinh Hoang Cassebee

Sheldon E Yourist

Larry M Taylor

Anthony Robert Geonnotti, Iii

Emma Louise Hubert

Cindy Stadelmaier

Yuji Ikeda

Dirk Puderbach

Roland Schultz

Peter Braun

Bjarne Høltzermann

Thomas Joseph Zuber

Richard K Tanaka

James H Comly

Ori Ben-David

Shai Peretz

Lanny D Baker

Monica A Kapil

Fabrizio Camplone

Cedric Gysel

Carl Feducia

Loren Kulesus

Eran Nemlich Naron

Jimmy Cassebee

Alan Moffat

Thomas Joseph Anthony Zuber

Kolbi Rega

James Flint

William Kang

Agnes Becker

Jungli Wang

Christina Sperry

David Ramos

Dolores PÉREZ

Drug delivery system

Intranasal drug delivery device

Dual vial holder

The present invention provides devices and methods for treating depression in a patient, comprising administering to the patient in need of the treatment a therapeutically effective amount of esketamine. In some embodiments, the depression is major depressive disorder or treatment resistant depression. In other embodiments, the therapeutically effective amount is clinically proven safe and/or effective. Also provided are methods to mitigate the risk or misuse or abuse of esketamine, instructions for use of the esketamine product, and methods for selling a drug product containing esketamine.

Delivery of esketamine for the treatment of depression

A grip accessory for a manual injection device comprises a housing having a generally hollow body for supporting a manual injection device therein. The housing comprises a distal portion comprising a first opening into which a manual injection device can be inserted, a proximal portion comprising a second opening through which a needle of the manual injection device is extendable, the proximal portion comprising a skin contacting surface at a proximal end of the device. An intermediate portion extends between the proximal and distal portions and guide means is provided on an interior surface of the distal portion for guiding a plunger rod of an injection device during delivery of an injection.

Grip accessory for a manual injection device

Package

A grip accessory for a manual injection device comprises a housing comprising a generally hollow body configured to support a manual injection device therein. The housing comprises a distal portion comprising a first opening into which a manual injection device can be inserted, a proximal portion having a second opening through which the needle of the manual injection device extends. The proximal portion comprises a skin contacting surface at a proximal end of the device that can be placed against an injection site. An intermediate portion extends between the proximal and distal portions.

An injection device comprises a housing having a proximal end, a distal end and a longitudinal axis extending therebetween. The housing has a hand grip portion with a non-rotationally symmetric cross section about the longitudinal axis of the device at the proximal end of the housing.

Injection device with ergonomic housing form factor

Combined package with drug delivery device

Pharmaceutical package

Autoinjector

Growing community of inventors

Atlantic Highlands, NJ, United States of America

Michael G Cannamela